FIELD: medicine. SUBSTANCE: method involves administering Ecdisteron for preventing blood viscosity and spontaneous erythrocyte aggregation growth. EFFECT: enhanced effectiveness of treatment. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
DRUG DECREASING ERYTHROCYTE AGGREGATION | 1996 |
|
RU2123848C1 |
HEMORHEOLOGICAL AGENT | 1998 |
|
RU2141320C1 |
HEMORHEALOGICAL AGENT | 1998 |
|
RU2150282C1 |
HEMORHEOLOGICAL AGENT | 1998 |
|
RU2138285C1 |
HEMORHEOLOGICAL AGENT AND METHOD OF ITS PREPARING | 1998 |
|
RU2138284C1 |
HEMORHEOLOGICAL AGENT AND METHOD OF ITS PREPARING | 1998 |
|
RU2191027C2 |
REMEDY HAVING ANTIAGGREGANT ACTIVITY, ACTIVITY DECREASING BLOOD HYPERVISCOSITY AND ANTITHROMBOGENIC ACTIVITY | 2008 |
|
RU2368376C1 |
OSMOTIC DIURETIC POSSESSING ANTITOXIC ACTIVITY IN CASE OF ALIPHATIC ALCOHOL POISONING | 2007 |
|
RU2354390C2 |
AGENT ELICITING ANTIAGGREGATIVE AND HEMORHEOLOGICAL ACTIVITY | 2001 |
|
RU2180848C1 |
AGENTS WITH HEMORHEOLOGICAL, ANTIAGGREGANT AND ANTITROMBOGENIC ACTIVITY | 2007 |
|
RU2347561C2 |
Authors
Dates
2000-12-20—Published
1996-09-11—Filed